DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
about
Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantationNomenclature for factors of the dog major histocompatibility system (DLA), 1998. First report of the ISAG DLA Nomenclature Committee. International Society for Animals Genetics.A preclinical model of double- versus single-unit unrelated cord blood transplantation.Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD.A preclinical canine model for composite tissue transplantationImmunomodulatory effects of mixed hematopoietic chimerism: immune tolerance in canine model of lung transplantation.Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.Extracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: role in engraftment.Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantationImmunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantationCanine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.Anti-CD28 Antibody-Initiated Cytokine Storm in Canines.CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model.Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioningHematopoietic cell transplantation directly into dystrophic muscle fails to reconstitute satellite cells and myofibersDevelopment of a Minor Histocompatibility Antigen Vaccine Regimen in the Canine Model of Hematopoietic Cell Transplantation.Canine DLA-79 gene: an improved typing method, identification of new alleles and its role in graft rejection and graft-versus-host diseaseHematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogsInducible costimulator (ICOS) up-regulation on activated T cells in chronic graft-versus-host disease after dog leukocyte antigen-nonidentical hematopoietic cell transplantation: a potential therapeutic target.Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerismMinor Antigen Vaccine-Sensitized DLI: In Vitro Responses Do Not Predict In Vivo Effects.Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantationComparing high and low total body irradiation dose rates for minimum-intensity conditioning of dogs for dog leukocyte antigen-identical bone marrow graftsTransmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia modelFive decades of progress in haematopoietic cell transplantation based on the preclinical canine model.Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation.A Canine Model of Chronic Graft-versus-Host Disease.Methylguanine methyltransferase-mediated in vivo selection and chemoprotection of allogeneic stem cells in a large-animal model.Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model.Evidence for evolutionary convergence at MHC in two broadly distributed mesocarnivores.Plerixafor-moblized stem cells alone are capable of inducing early engraftment across the MHC-haploidentical canine barrier.Nomenclature for factors of the dog major histocompatibility system (DLA), 2000: Second report of the ISAG DLA Nomenclature Committee.Nomenclature for factors of the dog major histocompatibility system (DLA), 1998: first report of the ISAG DLA Nomenclature Committee.Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease.DLA-DQB1 alleles and bone marrow transplantation experiments in narcoleptic dogs.Mixed chimerism renders residual host dendritic cells incapable of alloimmunization of the marrow donor in the canine model of allogeneic marrow transplantation.Nomenclature for factors of the dog major histocompatibility system (DLA), 2000: second report of the ISAG DLA Nomenclature Committee.
P2860
Q33398529-94E16831-E90C-4EC8-B271-183BF52C5A26Q33750948-E758DBE1-95E1-4FB7-BCA4-02F596956CF1Q33965521-1A36B4CB-7D3E-4890-BC76-FA44C043B63BQ34135339-20DBBDA9-EDE2-4B54-B1E6-E65874F52C91Q34286899-45E83500-DAC3-4515-9BAC-0921BCFDE019Q34422836-662E7329-C403-4CFF-A3CB-33FB2EB8053CQ34520475-75B36D9A-CE8C-4471-82E4-F1C75C8A2458Q35050513-2174D6D7-32CA-4C82-8293-6ED34FFF25E6Q35234495-FBCD8A90-D5EB-4364-A5A9-0818A48AAC69Q35375005-84330D71-CB25-4EBD-92FE-A68869426F1CQ35599947-8F71EFD2-E5D6-4AF5-B405-BE269AF62428Q35610659-DF8841FE-5940-4D3E-A219-92BF73DA152DQ35695151-F65F14E2-2FEC-4BCA-BB57-74EA2CF152B0Q35847785-BC3F687A-64F1-4783-A6EA-8064FCB99391Q35850707-E2FF968A-85A8-4AB6-88D3-F0B7B87BC452Q36013604-1C2762AC-6634-4E73-AB90-647D1F8EF5CBQ36113141-457C871A-64F4-4D01-8607-AEEA7EA2ED6EQ36708751-9ADA2F62-79D1-4A19-9AD8-3D62111D9DCAQ36876597-BEFCE864-5627-4BE8-BFE0-1DF41285CAA4Q36966278-15BBA712-94F2-41A5-9AAB-EE7FCED1BE75Q37016470-7E3119B8-353A-4EF7-9D83-DD7027E7501BQ37092112-5F32C33D-15B7-406E-BDB1-D7C4500CF68AQ37196123-B164610E-138D-4473-8E6B-8642B4559F2BQ37287517-0F0FECDB-FA61-4CAE-B041-4E7ABB8790C4Q37357517-7780277D-4AC8-49FC-B73A-659B16C813B3Q37363004-0C1F8DAB-80A8-4219-BE83-402E074337EBQ37366120-13BD34ED-49D4-4CE9-BB52-24EEC59ECDC2Q37375483-EB69CBBE-C2C0-4F86-AFBE-2028A86D1869Q38778387-89CFDFFB-B25B-4388-A73F-C959B710EE81Q40156537-87A27D9E-2D81-404D-B954-25F540CD8283Q41843443-0C075486-CDC8-4A6C-BAB0-6D5A455292A5Q42625117-F651DF8C-B7A3-4BDD-BE0A-D9CA2E682595Q42924622-FEAE15CA-59E8-4AD6-A3DF-BABD4958CDABQ48737499-1A83C1A9-86B5-4895-9112-AB9A2D72318CQ48752437-D476B641-224A-4615-B187-07BB3A0165FEQ49662013-5F7BAEF1-776E-4489-ADB5-9C667C9D5F6CQ52541275-3146CB30-7AA9-4533-9875-557C176F2FDEQ52913072-0E523C68-0BC6-47C5-955A-9B57517C8768Q53322516-DC649013-5B4B-413C-81BD-8BEF947E84AF
P2860
DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
@en
DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
@nl
type
label
DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
@en
DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
@nl
prefLabel
DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
@en
DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
@nl
P1433
P1476
DLA-DRB1 and DLA-DQB1 histocompatibility typing by PCR-SSCP and sequencing.
@en
P2093
P304
P356
10.1111/J.1399-0039.1998.TB03063.X
P577
1998-10-01T00:00:00Z